Works matching DE "PLIVA Inc. v. Mensing (Supreme Court case)"
Results: 7
Taking the "Product" Out of Product Liability: Litigation Risks and Business Implications of Innovator and Co-Promoter Liability.
- Published in:
- Defense Counsel Journal, 2015, v. 82, n. 3, p. 295, doi. 10.12690/0895-0016-82.3.295
- By:
- Publication type:
- Article
Too Good To Last? Will the FDA'S Proposed Rule Put an End to Generic Drug Preemption Under Mensing and Bartlett?
- Published in:
- Defense Counsel Journal, 2015, v. 82, n. 1, p. 28, doi. 10.12690/IADC-15-002
- By:
- Publication type:
- Article
New FDA Rule on Drug Labeling May Mean Increased Exposure and an Uncertain Path for Generic Pharmaceutical Manufacturers.
- Published in:
- Defense Counsel Journal, 2014, v. 81, n. 3, p. 306
- By:
- Publication type:
- Article
GETTING EVEN LESS THAN WHAT THEY PAID FOR: THE PLIGHT OF GENERIC DRUG CONSUMERS UNDER THE LEVINE-MENSING DICHOTOMY.
- Published in:
- University of Colorado Law Review, 2015, v. 86, n. 1, p. 259
- By:
- Publication type:
- Article
A First Amendment Approach to Generic Drug Manufacturer Tort Liability.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
PLIVA, INC. V. MENSING: HOW GENERIC-DRUG MANUFACTURERS AVOIDED LIABILITY FOR "FAILURE TO WARN" TORT CLAIMS.
- Published in:
- Loyola Law Review, 2012, v. 58, n. 1, p. 251
- By:
- Publication type:
- Article
Post-Mensing "Immunity" Under the Louisiana Products Liability Act: Johnson v. Teva Phaimaceuticals USA, Inc., and Its Implications for Louisiana Law.
- Published in:
- Tulane Law Review, 2015, v. 89, n. 4, p. 959
- By:
- Publication type:
- Article